Studies suggested that the expression of INMT is downregulated in lung cancer, meningioma, and prostate cancer (Kopantzev et al., 2008; Larkin et al., 2012; Schulten et al., 2016); however, its role and mechanism in cancer, especially prostate cancer, remain unclear. Here, INMT is linked to prostate carcinoma.